Remove Genetic Analysis Remove Life Science Remove Marketing
article thumbnail

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

Industry professionals will explore the market, innovative formulations and nutritional solutions tailored to empower women toward optimal health and well-being. A significant 58 percent of women worldwide have heightened their use of supplements to support overall wellness.

Genetics 115
article thumbnail

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

XTalks

With this has come an increase in the size of the global clinical trials market, with an estimated worth of around $46.8 In 2019 alone, worldwide pharma revenues totaled $1.25 trillion, with oncologics accounting for $99.5 billion in 2019.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bridging Gaps in Rare Disease Clinical Trials: Insights from Collaborative Success in Pompe Disease Research

XTalks

Next-generation sequencing (NGS) allows for efficient analysis of known genetic mutations, enhancing diagnostic accuracy. Overall, the diagnostic process for LOPD typically involves a series of assessments, including clinical, laboratory and imaging tests, culminating in genetic analysis to confirm the diagnosis.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

The global market for cell and gene therapies , valued at $5.9 The market for molecular diagnostics was valued at $25 billion in 2022 and is projected to grow at a CAGR of over 3.5 The global stem cell market was valued at $15.07 The global next-generation biomanufacturing market is projected to grow at a CAGR of 14.85